Pharmaceutical company cites Vatican document to defend its use of aborted baby

A pro-life group is criticizing pharmaceutical company Neocutis’ defense of its use of cells harvested from an aborted fetus in the development of burn treatments and anti-aging creams. While the company said it takes seriously concerns about the dignity of human life—going so far as to cite a Vatican document—the pro-life group is questioning Neocutis’ version of the facts.

Last week the organization Children of God for Life released a statement criticizing Neocutis’ use of cells harvested from an aborted fetus in the development of anti-aging creams. The group also called for a boycott.

The “Processed Skin Proteins” (PSPs) being used in Neocutis’ burn and wound treatments were reportedly taken from an electively-aborted 14-week-old male fetus donated by the University Hospital of Lausanne in Switzerland.

The baby’s cells were used to create a working cell bank by laboratory cultivation. The cells now number in the hundreds of millions.

Continue reading this story…